Valeant Gets Medicis In Skin Drug Merger | Chemical & Engineering News
Volume 90 Issue 37 | p. 17 | Concentrates
Issue Date: September 10, 2012

Valeant Gets Medicis In Skin Drug Merger

Department: Business
Keywords: dermatology, pharmaceuticals, acquisition

Valeant Pharmaceuticals has signed a $2.6 billion cash deal to acquire Medicis Pharmaceutical, based in Scottsdale, Ariz. The Canadian firm will pay $44.00 per share, or about one-third more than Medicis’ recent share price. Medicis sells prescription skin-enhancing and dermatology products. Valeant expects the combined company to have more than $1.7 billion in dermatology product sales this year. Valeant will operate its dermatology business under the Medicis name, with headquarters in Arizona and R&D in the U.S. and Canada.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment